首页> 美国卫生研究院文献>Acta Crystallographica Section F: Structural Biology and Crystallization Communications >On the purification and preliminary crystallographic analysis of isoquinoline 1-oxidoreductase from Brevundimonas diminuta 7
【2h】

On the purification and preliminary crystallographic analysis of isoquinoline 1-oxidoreductase from Brevundimonas diminuta 7

机译:短小Brevundimonas diminuta 7异喹啉1-氧化还原酶的纯化和初步晶体学分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Isoquinoline 1-oxidoreductase (IOR) from Brevundimonas diminuta is a mononuclear molybdoenzyme of the xanthine-dehydrogenase family of proteins and catalyzes the conversion of isoquinoline to isoquinoline-1-one. Its primary sequence and behaviour, specifically in its substrate specificity and lipophilicity, differ from other members of the family. A crystal structure of the enzyme is expected to provide an explanation for these differences. This paper describes the crystallization and preliminary X-ray diffraction experiments as well as an optimized purification protocol for IOR. Crystallization of IOR was achieved using two different crystallization buffers. Streak-seeding and cross-linking were essential to obtain well diffracting crystals. Suitable cryo-conditions were found and a structure solution was obtained by molecular replacement. However, phases need to be improved in order to obtain a more interpretable electron-density map.
机译:来自Brevundimonas diminuta的异喹啉1-氧化还原酶(IOR)是黄嘌呤-脱氢酶家族蛋白的单核钼酶,催化异喹啉向异喹啉-1-one的转化。它的主要序列和行为,特别是其底物特异性和亲脂性,不同于该家族的其他成员。该酶的晶体结构有望为这些差异提供解释。本文介绍了结晶和初步X射线衍射实验,以及针对IOR的优化纯化方案。使用两种不同的结晶缓冲液可实现IOR的结晶。条纹播种和交联对于获得衍射良好的晶体至关重要。发现合适的低温条件,并通过分子置换获得结构溶液。但是,需要改进相位以获得更可解释的电子密度图。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号